Anaerobic bacteremia in a neutropenic patient with oral mucositis.
An increasing number of anaerobic bloodstream infections in neutropenic cancer patients have been reported in the last decade. The type of anaerobes isolated from most of these patients suggests an oral source of infection. We describe a case of anaerobic bacteremia in a neutropenic patient with oral mucositis that highlights the importance of considering these organisms when selecting empiric prophylactic or therapeutic antimicrobial regimens, especially in the setting of periodontal disease or oral mucositis.
Vidal
A M
AM
Section of Infectious Diseases, Texas Tech University Health Sciences Center, Lubbock 79430, USA.
Sarria
J C
JC
Kimbrough
R C
RC
Keung
Y K
YK
D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D016470:Bacteremia / Q000188:drug therapy / Q000382:microbiology*; D001421:Bacteria, Anaerobic / Q000302:isolation & purification*; D003561:Cytarabine / Q000009:adverse effects; D005051:Eubacterium / Q000302:isolation & purification; D005675:Fusobacterium necrophorum / Q000302:isolation & purification; D006801:Humans; D015255:Idarubicin / Q000009:adverse effects; D015479:Leukemia, Myelomonocytic, Acute / Q000188:drug therapy; D008297:Male; D009061:Mouth Mucosa / Q000382:microbiology; D009503:Neutropenia / Q000139:chemically induced* / Q000150:complications*; D013280:Stomatitis / Q000188:drug therapy / Q000382:microbiology*
D000900:Anti-Bacterial Agents; D003561:Cytarabine; D015255:Idarubicin